ACTIVATING POINT MUTATION OF BRCA1/2 GENES IN AZERBAIJAN POPULATION
- Authors: Aliyev J.A1, Melikova L.A1, Mansurov E.B1, Aliyeva F.K1, Bagirova E.E1, Mexdizade S.Q1, Nadjafova A.S1
-
Affiliations:
- National Center of Oncology
- Issue: Vol 17, No 2 (2019)
- Pages: 39-43
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2918/article/view/113063
- DOI: https://doi.org/10.29296/24999490-2019-02-05
- ID: 113063
Cite item
Abstract
Full Text
About the authors
J. A Aliyev
National Center of OncologyBaku, Azerbaijan
L. A Melikova
National Center of Oncology
Email: Lmelikova20027@gmail.com
Baku, Azerbaijan
E. B Mansurov
National Center of OncologyBaku, Azerbaijan
F. K Aliyeva
National Center of OncologyBaku, Azerbaijan
E. E Bagirova
National Center of OncologyBaku, Azerbaijan
S. Q Mexdizade
National Center of OncologyBaku, Azerbaijan
A. S Nadjafova
National Center of OncologyBaku, Azerbaijan
References
- Алиев Д.А., Марданлы Ф.А., Ватанха С.С., Мансуров Э.Б. Эпидемиологические аспекты заболеваемости раком молочной железы в Азербайджанской Республике за период 2012-2016 гг. Azerbaijan J. of Oncology. 2017; 1: 76-8. (Aliyev J.A., Mardanli FA., Vatankha S.S., Mansurov E.B. Epidemiological aspects of the incidence of breast cancer in the Republic of Azerbaijan for the period 2012-2016. Azerbaijan Oncology J. 2017; 1: 76-8 (in Russian)]
- Statistical yearbook of Azerbaijan. State statistical committee of the republic of Azerbaijan. 2017; 824.
- Lynch H.T., Snyder C., Lynch J. Hereditary breast cancer: practical pursuit for clinical translation. Annals of Surgical Oncology. 2012; 19 (6): 1723-31.
- Deng C.X., Wang R.H. Roles of BRCA1 in DNA damage repair: a link between development and cancer. Human Molecular Genetics. 2003; 12 (1): 113-23.
- NHGRI: Breast Cancer Information Core. https://research.nhgri.nih.gov/bic/
- Любченко Л.Н., Батенева Е.И., Воротников И.К. Портной С.М., Крохина О.В., Соболевский В.А., Жукова Л.Г., Хайленко В.А., Тюляндин С.А. Наследственный рак молочной железы: генетическая и клиническая гетерогенность, молекулярная диагностика, хирургическая профилактика в группах риска. Успехи молекулярной онкологии. 2014; 2: 16-25.
- Дмитриев И.В., Сухотерин И.И., Зыбенко Т.В., Дмитриева Т.В. Мутации генов BRCA 1, BRCA 2 - будущее предикативной онкологии: обзор литературы. Маммология. 2012; 1: 13-6. (Dmitriev I.V., Sukhoterin I.I., Zibenko T.V., Dmitrieva T.V. Mutation of the genes BRCA1, BRCA2 - the future of predictive Oncology: a review of the literature. Mammalogy. 2012; 1: 13-6 (in Russian)]
- Hyuna Sung, Philip S. Rosenberg, Wan-Qing Chen et al. Female Breast Cancer Incidence among Asian and Western Populations: More Similar Than Expected. J. of the National Cancer Institute. 2015; 107 (7): 107.
- Fatemeh K., Parvin M. A comprehensive Focus on Global Spectrum of BRCA1 and BRCA2 mutations in breast cancer. BioMed Research International. 2013; 928562: 21. http://dx.doi.org/10.1155/2013/928562
- Pohlreich P., Michal Z., Jana S.High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area. Breast cancer research. 2005; 7 (5): 728-36.
- Antoniou A.C., Pharoah P.D., Narod S., Risch H.C., et al. Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies. Letter to JMG. 2010; 42 (7): 5-7.
- Balci A., Huusko P., Paakkonen K. et al. Mutation analysis of BRCA1 and BRCA2 in Turkish cancer families: a novel mutation BRCA2 3414del4 found in male breast cancer. European J. of Cancer. 1999; 35 (5): 707-10.